Providence School Board President Erlin Rogel said the said the board received a presentation on the district’s recent ...

Despite our protestations, Microsoft is determined to make AI tools in the workplace accessible and appealing with a raft of ...

Thompson School District staff presented data and analysis of the district’s most recent statewide assessments to the Thompson School Board during their meeting Wednesday evening, reporting record ...

The paper, published by the Greenbelt Cooperative Publishing Association, Inc., was established in 1937 shortly after the ...

Neuraptive Therapeutics Inc., a leading biopharmaceutical company focused on novel treatments for peripheral nerve injuries, ...

The HIMALAYA study showed that the combination of tremelimumab and durvalumab significantly improved overall survival in ...

UNION therapeutics A/S (UNION), a privately held, clinical stage, pharmaceutical development company focused on immunology, today announced ADESOS Phase 2b results selected as a late-breaking oral ...

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today a ...

Presentations made by Pliant colleagues and investigators at the 2024 ERS Congress include additional clinical data from our recently announced type 1 collagen PET imaging study, an integrated safety ...

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing ...

Subcutaneous and intravenous forms of rituximab showed similar efficacy in patients with non-Hodgkin lymphoma.

Novocure (NASDAQ: NVCR) announced today it will present a real-world analysis of usage of its Tumor Treating Fields (TTFields) therapy and survival outcomes in newly diagnosed glioblastoma (ndGBM) ...